ABAX Abaxis, Inc. (delisted)

UNION CITY, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will participate in a panel discussion titled "Getting To The Point Of Care" on Thursday, December 11, 2008 at 9:00 a.m. ET. The RBC Capital Markets 2008 Healthcare Conference will be held at the Westin New York Times Square hotel in New York City. About Abaxis Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. Contact: Clint Severson Lytham Partners, LLC Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700 510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT: Joe Dorame, Joe Diaz or Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, for Abaxis; or Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500

Copyright